Dilan Athauda

6PUBLICATIONS
25CO-AUTHORS
PharmacogenomicsMajor global burdens of diseasePredictive and prognostic markersBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber

|Aug 22, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials.

Nirosen Vijiaratnam, Christine Girges, Dilan Athauda

|Jun 14, 2022
The Impact of Type 2 Diabetes in Parkinson's Disease.

Dilan Athauda, James Evans, Anna Wernick

|May 16, 2022
Combining biomarkers for prognostic modelling of Parkinson's disease.

Nirosen Vijiaratnam, Michael Lawton, Amanda J Heslegrave

|Aug 03, 2018
Post hoc analysis of the Exenatide-PD trial-Factors that predict response.

Dilan Athauda, Kate Maclagan, Natalia Budnik

Pageof 1